-
Publication Venue For
-
Sex differences in progression of kidney disease in sickle cell disease..
108:1436-1441.
2023
-
A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia..
108:705-716.
2023
-
Variation and impact of polygenic hematologic traits in monogenic sickle cell disease..
108:870-881.
2023
-
Improved outcomes with "7+3" induction chemotherapy for acute myeloid leukemia over the past four decades: analysis of SWOG trial data..
108:42-47.
2023
-
Patient- and physician-reported pain after tyrosine kinase inhibitor discontinuation among patients with chronic myeloid leukemia..
107:2641-2649.
2022
-
Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis..
107:899-908.
2022
-
Integrating genetic and epigenetic factors in chronic myeloid leukemia risk assessment: toward gene expression-based biomarkers..
107:358-370.
2022
-
Molecular and phenotypic diversity of CBL-mutated juvenile myelomonocytic leukemia..
107:178-186.
2022
-
Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration..
106:2845-2852.
2021
-
Transducin β-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphoma..
106:2927-2939.
2021
-
Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research..
106:2295-2296.
2021
-
Rapid decline in estimated glomerular filtration rate in sickle cell anemia: results of a multicenter pooled analysis..
106:1749-1753.
2021
-
Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia..
106:284-287.
2021
-
Pyridoxamine: another vitamin for sickle cell disease?.
105:2348-2350.
2020
-
Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract..
105:1895-1906.
2020
-
Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research..
105:1329-1338.
2020
-
Genomic and outcome analysis of adult T-cell lymphoblastic lymphoma..
105:e107-e110.
2020
-
Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses..
104:e558-e561.
2019
-
Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study..
104:1974-1983.
2019
-
Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors..
104:844-854.
2019
-
Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study..
104:e51-e53.
2019
-
A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801..
103:1915-1924.
2018
-
Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States..
103:1511-1517.
2018
-
Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis..
103:874-879.
2018
-
A germ-line deletion of APOBEC3B does not contribute to subtype-specific childhood acute lymphoblastic leukemia etiology..
103:e29-e31.
2018
-
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases..
102:1823-1832.
2017
-
A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndrome..
102:1112-1119.
2017
-
Relationship between event-free survival and overall survival in acute myeloid leukemia: a report from SWOG, HOVON/SAKK, and MRC/NCRI..
101:e284-e286.
2016
-
Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG..
100:e409-e411.
2015
-
Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I..
100:479-488.
2015
-
Cytogenetic heterogeneity negatively impacts outcomes in patients with acute myeloid leukemia..
100:331-335.
2015
-
Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation..
99:1868-1875.
2014
-
Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies..
99:292-298.
2014
-
Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I..
98:1865-1871.
2013
-
In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline..
98.
2013
-
In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline..
98:e92-e94.
2013
-
Quality of life in higher resolution: the next generation of comparative effectiveness research in malignant hematology..
98:823-824.
2013
-
Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study..
98:255-263.
2013
-
Late stage erythroid precursor production is impaired in mice with chronic inflammation..
97:1648-1656.
2012
-
A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype..
97:758-765.
2012
-
Family-directed umbilical cord blood banking..
96:1700-1707.
2011
-
Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study..
96:1488-1495.
2011
-
Non-erythroid effects of erythropoietin..
95:1803-1805.
2010
-
SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype..
94:1555-1562.
2009
-
Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma..
93:1327-1334.
2008
-
Deficiency of heme-regulated eIF2alpha kinase decreases hepcidin expression and splenic iron in HFE-/- mice..
93:753-756.
2008
-
Adhesion molecules and hydroxyurea in the pathophysiology of sickle cell disease..
93:481-485.
2008
-
Ultrastructural analysis of granulocyte inclusions in genetically confirmed MYH9-related disorders..
89:330-337.
2004